Knowing When to Call It Quits in Drug Development and Healthcare Innovations

In this episode of BDO’s Health & Life Sciences Rx Podcast, BDO’s Howard Levine sits down with leaders from the Allen Institute for Brain Science, Comet Therapeutics, and McDermott Will & Emery to discuss how life sciences leaders can evaluate whether to continue pursuing a drug development program or cancel it.